India's Pharmaceutical Exports

Country Profile

Taiwan

Taiwan is a growing market for Indian pharmaceuticals — $71.9M in FY 2025–26, with 2.1× growth over the past decade. Medicine Ingredients accounts for 54% of shipments, with vaccines contributing $756K. The compound annual growth rate since FY2015 stands at 7.0%.

🇹🇼 $71.9M · 2.1× growth since FY2015 · 7.0% CAGR
Single-source profile. All data from DGCIS India export records (fiscal year, April–March).
$71.9M
Exports FY2025–26 DGCIS
2.1×
Growth FY2015→2026
7.0%
CAGR FY2015→2026
54%
Medicine Ingredients Share
5
Product Categories Supplied
Taiwan is a growing market for Indian pharmaceuticals — $71.9M in FY 2025–26, with 2.1× growth over the past decade. Medicine Ingredients accounts for 54% of shipments, with vaccines contributing $756K. The compound annual growth rate since FY2015 stands at 7.0%.
Export Trend DGCIS FY
Category Mix — FY 2025–26 DGCIS
Medicine Ingredients $39.0M (54.3%) Medicines $29.0M (40.3%) Traditional & Herbal $1.68M (2.3%) Surgical & Hospital Supplies $1.42M (2.0%) Vaccines $756K (1.1%)
Top 10 Products — FY 2025–26 DGCIS
Indian Pharma Investment Source: RBI ODI Data

No recorded pharmaceutical sector investment transactions from Indian companies to Taiwan in the RBI overseas direct investment dataset (2011–2026).